These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29573975)

  • 41. The evening versus morning polypill utilization study: the TEMPUS rationale and design.
    Lafeber M; Grobbee DE; Bots ML; Thom S; Webster R; Rodgers A; Visseren FL; Spiering W
    Eur J Prev Cardiol; 2014 Apr; 21(4):425-33. PubMed ID: 23382539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cut stroke in half: Polypill for primary prevention in stroke.
    Brainin M; Feigin V; Martins S; Matz K; Roy J; Sandercock P; Teuschl Y; Tuomilehto J; Wiseman A
    Int J Stroke; 2018 Aug; 13(6):633-647. PubMed ID: 29461155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospects for a cardiovascular disease prevention polypill.
    Dabhadkar KC; Kulshreshtha A; Ali MK; Narayan KM
    Annu Rev Public Health; 2011; 32():23-38. PubMed ID: 21219156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.
    Coca A; Agabiti-Rosei E; Cifkova R; Manolis AJ; Redón J; Mancia G
    J Hypertens; 2017 Aug; 35(8):1546-1553. PubMed ID: 28448291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reconsidering the Polypill for Management of Cardiovascular Risk Factors in Underserved Patients.
    Macaulay TE; Sheridan E; Ward S
    Curr Cardiol Rep; 2021 Feb; 23(3):19. PubMed ID: 33598864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patients' and providers' perspectives of a polypill strategy to improve cardiovascular prevention in Australian primary health care: a qualitative study set within a pragmatic randomized, controlled trial.
    Liu H; Massi L; Laba TL; Peiris D; Usherwood T; Patel A; Cass A; Eades AM; Redfern J; Hayman N; Howard K; Brien JA; Jan S
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):301-8. PubMed ID: 25944629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial.
    Selak V; Harwood M; Raina Elley C; Bullen C; Wadham A; Parag V; Rafter N; Arroll B; Bramley D; Crengle S
    Eur J Prev Cardiol; 2016 Sep; 23(14):1537-45. PubMed ID: 26928727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fixed-dose combination therapy (polypill) for the prevention of cardiovascular disease.
    Huffman MD; de Cates AN; Ebrahim S
    JAMA; 2014 Nov; 312(19):2030-1. PubMed ID: 25399279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polypill treatments for cardiovascular diseases.
    Webster R; Rodgers A
    Expert Opin Drug Deliv; 2016; 13(1):1-6. PubMed ID: 26558898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polypill Therapy in Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials.
    Hennawi HA; Ashraf MT; Zohaib M; Khan MK; Khan IA; Muhammadzai HZU; Memon RA; Sadiq U; Siddiqi A; Roomi S; Nair A
    Curr Probl Cardiol; 2023 Aug; 48(8):101735. PubMed ID: 37044270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol.
    Merat S; Poustchi H; Hemming K; Jafari E; Radmard AR; Nateghi A; Shiravi Khuzani A; Khoshnia M; Marshall T; Malekzadeh R
    Arch Iran Med; 2015 Aug; 18(8):515-23. PubMed ID: 26265520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.
    Barrios V; Kaskens L; Castellano JM; Cosin-Sales J; Ruiz JE; Zsolt I; Fuster V; Gracia A
    Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):42-49. PubMed ID: 27474481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration.
    Webster R; Patel A; Billot L; Cass A; Burch C; Neal B; Usherwood T; Thom S; Poulter N; Stanton A; Bots ML; Grobbee DE; Prabhakaran D; Reddy KS; Field J; Bullen C; Elley CR; Selak V; Rafter N; Wadham A; Berwanger O; Rodgers A;
    Int J Cardiol; 2013 Dec; 170(1):30-5. PubMed ID: 24144927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polypill in cardiovascular disease prevention: recent advances.
    Coca A; Castellano JM; Camafort M; Fuster V
    Pol Arch Intern Med; 2023 Mar; 133(3):. PubMed ID: 36916535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'Multiple action fixed combination. Present or future?'.
    García-Donaire JA; Ruilope LM
    Fundam Clin Pharmacol; 2010 Feb; 24(1):37-42. PubMed ID: 20002751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving cardiovascular protection: focus on a cardiovascular polypill.
    Barrios V; Escobar C
    Future Cardiol; 2016 Mar; 12(2):181-96. PubMed ID: 26652213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE
    Curr Hypertens Rep; 2016 Apr; 18(5):40. PubMed ID: 27083928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.
    Daviglus ML; Lloyd-Jones DM; Pirzada A
    Am J Cardiovasc Drugs; 2006; 6(2):87-101. PubMed ID: 16555862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polypill Trials for Stroke Prevention-Main Results, Critical Appraisal, and Implications for US Population.
    Ibraheem M; Goldstein LB
    Curr Neurol Neurosci Rep; 2020 Apr; 20(5):10. PubMed ID: 32296941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polypill: Progress and Challenges to Global Use--Update on the Trials and Policy Implementation.
    Webster R; Rodgers A
    Curr Cardiol Rep; 2015 Dec; 17(12):121. PubMed ID: 26497041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.